Naval Medical Research Unit South

Last updated

U.S. Naval Medical Research Unit SOUTH
Active1983–present
Country United States of America
Branch United States Department of the Navy Seal.svg United States Navy
RoleNAMRU SOUTH is the primary source of infectious diseases research in the Latin American region for the US Navy.
Size16 Active duty, 300 civilians
Part of Naval Medical Research Command (NMRC)
Garrison/HQHospital Centro Médico Naval
Lima, Peru
Website https://www.med.navy.mil/Naval-Medical-Research-Command/R-D-Commands/Naval-Medical-Research-Unit-SOUTH/
Commanders
Current
commander		 Captain Abigail Marter was just relieved of command. Awaiting new appointee. [1]

Naval Medical Research Unit SOUTH , formerly known as Naval Medical Research Unit Six, is a biomedical research laboratory of the U.S. Navy located in Lima, Peru. It is the only U.S. military command located in South America. Its mission is to identify infectious disease threats of military and public health importance and to develop and evaluate interventions and products to mitigate those threats. [1]

Contents

NAMRU SOUTH consists of 143,182 square feet (13,302.0 m2) of laboratory and office space in Lima and 5000 square feet of lab space in Iquitos, Peru. The Lima facility includes Biosafety Level 3 (BSL-3) facilities, while the other two laboratories are only biosafety level 2 rated. The Lima facility also contains a vivarium for animal research that is Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) certified.

Mission

Implementation of NAMRU SOUTH's mission is via threefold means:

  1. to investigate prophylactic agents such as vaccines and pharmaceuticals against tropical infectious diseases which cause severe mortality or morbidity to the US military member in the deployed environment. Generally the focus of study is ”orphan” illnesses with little or no investment by major pharmaceutical companies and includes parasitic infection such as malaria and leishmaniasis, viral diseases such as dengue fever and other arboviruses, and bacterial illnesses like traveler's diarrhea (ETEC, campylobacter, shigella).
  2. to augment public health and military medical infrastructure of host and partner nations by assisting in surveillance of outbreaks and providing laboratory surge capacity during pandemics.
  3. to provide assistance in training host nation scientists in epidemiologic techniques or modern laboratory molecular biology methods. Via these collaborations with partner nations, the NAMRU gets to conduct research on diseases that threaten troops on deployment but are not commonly seen in the US, and to get advanced notice of impending pandemics such as avian influenza that might affect military operational readiness. The host nation benefits by getting access to state of the art treatments and protection against diseases endemic to their country and a more robust public health infrastructure and better trained microbiology and physician population. This results in both military and political benefits to both nations and as such all NAMRU personnel are considered diplomats and counted as members of the US embassy in the host country.

Partner nations include ministries of Defense or Health in Honduras, El Salvador, Nicaragua, Venezuela, Ecuador, Argentina, Bolivia, Paraguay and Colombia. The lab conducts research throughout Peru including the cities and districts of Arequipa, Cuzco, Junin, La Libertad, Lambayeque, Madre De Dios, Piura, San Martin, Tumbes, Puno, Lima, Loreto and Ucayali. All animal research conducted at NAMRU SOUTH is subject to approval by an Institutional Animal Care and Use Committee (IACUC)and all human research conducted by NAMRU SOUTH is conducted under supervision of duly constituted Institutional Review Board (IRB).

History

Former NAMRU-6 logo NAMRU-6 logo.png
Former NAMRU-6 logo

The idea for what would become NAMRU South originated in 1978 with an idea of ADM Dileo-Paoli, the Peruvian Surgeon General, who proposed to the US Navy Surgeon General to establish a program of tropical medicine with joint participation between the US and Peruvian Navies. The command began with the arrival of 4 US Navy Active duty members under the Officer in Charge, CDR Michael Kilpatrick on January 20, 1983.

The detachment was signed into agreement on October 21, 1983, in Lima between Fernando Schwalb Lopez Aldan, Minister of Foreign Affairs of Peru and Ambassador Frank V. Ortiz. This agreement was further signed by RADM Jorge Tenorio De la Fuente, the Peruvian Surgeon General and VADM Lewis H. Seaton the US Navy Surgeon General in Washington, D.C., on November 14, 1983. On Jan 6th 1984, The US Chief of Naval Operations established the laboratory as a detachment of Naval Medical Research Institute, Bethesda, Maryland, it was then known as the acronym NMRID. In December 1983, Rear Admiral Roger F Milnes represented the US Navy Surgeon General in a ceremony laying the cornerstone of the new 7330 meter facility, jointly funded by the Peruvian and US Navies. This first building was inaugurated on July 4, 1985, by the President of Peru, the Architect Fernando Belaunde Terry and the US Ambassador David Jordan. An annex building for animal research was inaugurated in 1987. The facility was one of the first in Peru to be able to work with BSL-3 agents such as Brucella melitensis, Yersinia pestis and Venezuelan Equine Encephalitis. Additionally in July 1985, the first clinics of investigation were inaugurated on the grounds of the Naval Clinic in Iquitos, Peru.

In 1998, NMRID became part of the newly reorganized Naval Medical Research Command. [2] [3] The Base Re-alignment and Closure (BRAC) process had ordered the closure of NMRI on the Bethesda campus and its relocation to the Walter Reed Forest Glen Annex with Walter Reed Army Institute of Research, where it was established as Naval Medical Research Center (NMRC), NAMRID was subsequently renamed as NMRCD to reflect the change of name of its parent command. On 16 November 2010, NMRCD officially changed its command status from a detachment of NMRC with an officer-in-charge, to a full command, U.S. Naval Medical Research Unit No. 6 (NAMRU-6), with a commanding officer.

A modern laboratory facility was constructed and inaugurated in Iquitos in July 2005 by US Ambassador Curtis Struble and Vice Admiral Jose Ricardo Rafael Aste Daffos, the head of Amazonian Operations for the Peruvian Navy.

The civilian staff has been awarded the Department of the Navy Award of Merit for Group Achievement twice, once in 1990 and again from 1995 to 1997. Important scientific achievements include completing a Cholera vaccine field efficacy trial on 18,000 volunteers in Peru in 1993, development of an FDA approved rapid malaria diagnostic test (BinaxNow) from 1996 to 2001, the first clinical descriptions of Mayaro virus in 1999, the first identification of novel strains of dengue in Peru in 2000–1, investigations of HIV and hepatitis, conducting field efficacy trials resulting in region specific national malaria treatment guidelines in 2000, association of spotted fever rickettsia with an outbreak of febrile illness in 2004, demonstrating superiority of glucantime to pentamidine therapy for cutaneous leishmaniasis in 2005, developing non-human primate models of campylobacter and Enterotoxigenic Escherichia coli diarrhea, a field trial of two yellow fever vaccines in children in 2005, and the discovery of Iquitos virus in 2010.

In 2023, the laboratory was renamed U.S. Naval Medical Research Unit SOUTH to better reflect its geographical mission and commitment to Navy and regional partners in Central and South America.

Current activities

Related Research Articles

<span class="mw-page-title-main">Walter Reed Army Institute of Research</span> Biomedical research facility administered by the U.S. Department of Defense

The Walter Reed Army Institute of Research (WRAIR) is the largest biomedical research facility administered by the U.S. Department of Defense (DoD). The institute is centered at the Forest Glen Annex, in the Forest Glen Park part of the unincorporated Silver Spring urban area in Maryland just north of Washington, DC, but it is a subordinate unit of the U.S. Army Medical Research and Development Command (USAMRDC), headquartered at nearby Fort Detrick, Maryland. At Forest Glen, the WRAIR has shared a laboratory and administrative facility — the Sen Daniel K. Inouye Building, also known as Building 503 — with the Naval Medical Research Center since 1999.

The National Institute of Virology in Pune, India is an Indian virology research institute and part of the Indian Council of Medical Research (ICMR). It was previously known as 'Virus Research Centre' and was founded in collaboration with the Rockefeller Foundation. It has been designated as a WHO H5 reference laboratory for SE Asia region.

Carlos Carrillo Parodi, medical microbiologist, professor and founder of the University Cayetano Heredia, was National Coordinator of the Global Programme of eradication of smallpox in Peru in 1972, founding member of the Society of Infectious Diseases in 1978, and Head of the National Institute of Health in two periods. In 1992 he was National Coordinator of the programme for the eradication of cholera in Peru. Recognized as an expert in National Public Health and Climate Change in 1999/2001. In 2003, is incorporated as Academic number by the National Academy of Medicine, with more than 70 publications in national and international journals. Credited with the IDSA's Award Kass in 2004, in Boston and appointed Member of the Consultative Council of the Foundation Institute Hipolito Unanue in 2006.

<span class="mw-page-title-main">Mosquito-borne disease</span> Diseases caused by bacteria, viruses or parasites transmitted by mosquitoes

Mosquito-borne diseases or mosquito-borne illnesses are diseases caused by bacteria, viruses or parasites transmitted by mosquitoes. Nearly 700 million people contract mosquito-borne illnesses each year, resulting in more than a million deaths.

The International Vaccine Institute (IVI) is a non-profit, autonomous international organization established with the mandate of making vaccines available to all. Collaborating closely with the global scientific community, public health entities, governments, and industry stakeholders, IVI focuses on vaccine research and deployment. This includes conducting new vaccine designs in laboratories, advancing vaccine development and assessment in real-world settings, and facilitating the sustainable integration of vaccines in regions where they are most urgently required.

<span class="mw-page-title-main">Iquitos Satellite Laboratory</span>

The Iquitos Satellite Laboratory (IQTLAB) was established in 2002 in the city of Iquitos, Peru by doctor Margaret Kosek, biologist Maribel Paredes Olortegui, and nurse Pablo Peñataro Yori, with the collaboration of the Dr. Robert Gilman working group in Lima, Peru and the US Naval Medical Research Unit No. 6 (NAMRU-6).

Mayaro virus disease is a mosquito-borne zoonotic pathogen endemic to certain humid forests of tropical South America. Infection with Mayaro virus causes an acute, self-limited dengue-like illness of 3–5 days' duration. The causative virus, abbreviated MAYV, is in the family Togaviridae, and genus Alphavirus. It is closely related to other alphaviruses that produce a dengue-like illness accompanied by long-lasting arthralgia. It is only known to circulate in tropical South America.

Naval Medical Research Unit One was a research laboratory of the US Navy which was founded as Naval Laboratory Research Unit 1, a Naval Reserve Unit at the University of California Berkeley in the life sciences building in 1934 after a campaign by a Berkeley scientist Albert P. Krueger to the Bureau of Medicine and Surgery to have a laboratory to study and prevent influenza and respiratory infections in naval forces. It was mobilized as an active duty naval unit in 1941 to study the epidemiological impact of diseases such as influenza, meningitis, and catarrhal fever, as well as tropical diseases such as malaria on the US Navy during World War II.

The Naval Medical Research Unit Indo Pacific, formerly known as Naval Medical Research Unit Two (NAMRU-2), is a biomedical research laboratory of the US Navy established with the purpose to study infectious diseases of potential military significance in Asia. NAMRU-2 is officially registered as a subordinate command of Naval Medical Research Command located on Silver Spring, Maryland, U.S. and considered as the center network of laboratories around the world.

<span class="mw-page-title-main">Naval Medical Research Unit Four</span> Former US Navy research unit

Naval Medical Research Unit Four (NAMRU-4) was a research laboratory of the US Navy which was commissioned 31 May 1946 at the Naval Hospital in Dublin, Georgia as the Mcintire Research Unit for Rheumatic Fever, which was named for the Surgeon General of the United States Navy Ross T. Mcintire. Initial staffing was 4 physicians, 4 laboratory technicians and 4 laboratory helpers under the command of LCDR John R. Seal. Eighteen months after commissioning the Navy transferred Dublin Naval Hospital to the Veterans Affairs system and the Secretary of the Navy re-established NAMRU-4 at Great Lakes Naval Base on the grounds of the Naval Hospital to study acute respiratory diseases in military personnel with a focus on their prevention. Lieutenant Commander Seal remained the Officer in Charge. The location at Great Lakes made it ideal as this was a large recruit training command with members arriving from all over the United States and being housed in military barracks and therefore would be expected to experience outbreaks of respiratory illness periodically. Diseases studied included:

Naval Medical Research Unit Five (NAMRU-5) was a research laboratory of the US Navy which was founded as a field facility of Naval Medical Research Unit 3 in Addis Ababa Ethiopia with a collecting station in Gambella on December 30, 1965 under an agreement between the US and Ethiopian governments. In 1974 NAMRU-5 was established as its own command and was housed in the Ethiopian Health and Nutrition Research Institute. The mission of NAMRU-5 was to conduct research and development on infectious diseases of military importance in sub-Sahara Africa. Gambella became the focus of a major malaria control effort and studies on malaria immunology. Applied research focused on the general areas of insect repellents, insecticide resistance, insect attractants and louse control.

<span class="mw-page-title-main">Naval Medical Research Unit Three</span> U.S. Navy biomedical research laboratory

Naval Medical Research Unit Three (NAMRU-3) is a biomedical research laboratory of the US Navy located in Sigonella, Italy. Previously it was located in Cairo, Egypt. NAMRU-3 is the oldest U.S. overseas military medical research facility that has remained in the same location, and one of the largest medical research laboratories in the North Africa-Middle East region. The laboratory has been in continuous operation despite periods of political tension and a seven-year lapse in U.S.-Egyptian relations (1967–1973) since 1942.

<span class="mw-page-title-main">Makerere University Walter Reed Project</span>

Makerere University Walter Reed Project (MUWRP) was established in 2002 for the primary purpose of HIV vaccine development and building of vaccine testing capability in Uganda. It is one of the 5 international research sites established by the Department of Defense (DoD) United States HIV Research Program (MHRP), a program centered at the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland. MUWRP's main facility is centrally located in Kampala, near the Makerere University College of Health Sciences where the MUWRP laboratory is located. The main facility includes the clinic, administrative, and data offices.

Christopher Mores is an American (US) arbovirologist, trained in infectious disease epidemiology. He is a professor in the Department of Global Health at the Milken Institute School of Public Health, the program director for the Global Health Epidemiology and Disease Control MPH program, and is director of a high-containment research laboratory at the George Washington University in Washington, DC.

Dengue vaccine is a vaccine used to prevent dengue fever in humans. Development of dengue vaccines began in the 1920s, but was hindered by the need to create immunity against all four dengue serotypes. As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga.

<span class="mw-page-title-main">Naval Medical Research Command</span> Medical research and development command of the United States Navy

The Naval Medical Research Command (NMRC) is an agency that performs basic and applied biomedical research to meet the needs of the United States Navy and United States Marine Corps. Its areas of focus include study of infectious diseases, biodefense, military medicine, battlefield medicine, and bone marrow research. NMRC is under the United States Department of the Navy's Bureau of Medicine and Surgery.

The Armed Forces Research Institute of Medical Sciences (AFRIMS) is a United States Army project that started as a collaboration with the Government of Thailand to fight a cholera outbreak in Bangkok in 1958 and 1959. It subsequently expanded to conduct military medical research, primarily involving infectious diseases, across much of Southeast Asia and the Indian Subcontinent.

<span class="mw-page-title-main">Robert Shope</span> American virologist and epidemiologist

Robert Ellis Shope was an American virologist, epidemiologist and public health expert, particularly known for his work on arthropod-borne viruses and emerging infectious diseases. He discovered more novel viruses than any person previously, including members of the Arenavirus, Hantavirus, Lyssavirus and Orbivirus genera of RNA viruses. He researched significant human diseases, including dengue, Lassa fever, Rift Valley fever, yellow fever, viral hemorrhagic fevers and Lyme disease. He had an encyclopedic knowledge of viruses, and curated a global reference collection of over 5,000 viral strains. He was the lead author of a groundbreaking report on the threat posed by emerging infectious diseases, and also advised on climate change and bioterrorism.

<span class="mw-page-title-main">John P. Woodall</span> American entomologist

John Payne Woodall (1935–2016), known as Jack Woodall, was an American-British entomologist and virologist who made significant contributions to the study of arboviruses in South America, the Caribbean and Africa. He did research on the causative agents of dengue fever, Crimean–Congo hemorrhagic fever, o'nyong'nyong fever, yellow fever, Zika fever, and others.

A notifiable disease is one which the law requires to be reported to government authorities.

References

  1. 1 2 Ziezulewicz, Geoff (April 5, 2024). "Navy fires commander of biomedical research lab". Navy Times. Retrieved April 7, 2024.
  2. ↑ "Fort Detrick 2010 Post Guide" (PDF). U.S. Navy Bureau of Medicine and Surgery. 2010. pp. 6–9. Archived from the original (PDF) on October 10, 2011. Retrieved July 26, 2014.
  3. ↑ Chiarella, Donald (2005). History of Naval Medicine. Lulu.com. p. 89. ISBN   9781411659339.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.